These figures are from the HY report (released Feb 27) and the update (Mar 12).
Dec 31, 2014. 23 European centres + 20 US centres using Cardiocel.
Feb 27, 2015. 27 European centres + 25 US centres using Cardiocel, with 1000 patients.
Mar 12, 2015. 28 European centres + 28 US centres using Cardiocel, with 1200 patients. Here they announce "over 60 centres globally" as Cardiocel starts to spread beyond USA and Europe.
So basically we're waiting for the quarterly to tell us how much further Cardiocel has blossomed. It's clear the product is an unfolding success story -- we just need the company's financials to follow. I'm hoping we'll see signs that the revenue : spending ratio is improving.
Review of recent months
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |